Short Summary
Dexcom, Inc. initiated this IPR petition against Abbott Diabetes Care Inc.'s patent, challenging multiple claims based on obviousness. The core argument is that the patented features are merely predictable combinations of prior art references (Stafford, Raymond, and Turner).
Detailed Summary
Dexcom filed an Inter Partes Review (IPR) petition asserting grounds of obviousness under 35 U.S.C. § 103 against Abbott Diabetes Care Inc.'s patent covering Glucose Monitoring Systems/Inserters. The petitioner contends that claims 1, 2, 5, 6, and 7 are obvious over various combinations of prior art references, including Stafford, Raymond, and Turner. Specifically, the petition argues that POSITA would have been motivated to combine these references to solve known deficiencies in the individual disclosures, such as improving insertion mechanics or adding rotation-restricting features.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Dexcom, Inc. vs Abbott Diabetes Care Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Dyson Technology Limited et al.vsOmachron Intellectual Property Inc. et al.
Dyson and Omachron settled their inter partes review dispute over U.S. Patent 11,910,983 B2. The Board granted a joint motion to terminate the proceeding and treated the settlement agreement as confidential.
Deltran USA LLC et al.vsThe Noco Company
The PTAB held that all seven claims of The Noco Company's portable jump‑starter patent are unpatentable, finding them obvious over prior‑art jump‑starter and USB‑charging references. The decision follows a petition by Deltran USA LLC asserting obviousness under 35 U.S.C. § 103.
BabyBjorn AB et al.vsThe Ergo Baby Carrier, Inc. et al.
The PTAB denied the institution of an IPR challenge against The Ergo Baby Carrier's patent on adjustable baby carriers. Petitioner failed to meet its burden of persuasion, specifically regarding the public accessibility of key prior art and demonstrating a reasonable likelihood of prevailing on the merits.
TESLA, INC.vsiQar Inc.
Tesla successfully secured the institution of Inter Partes Review against iQar Inc.'s patent 10,829,002, challenging claims related to vehicle destination prediction and power management.
Abbott Laboratories et al.vsMIRACOR MEDICAL SA
Abbott Laboratories challenged MIRACOR MEDICAL SA's cardiac assist pump patents based on obviousness (35 U.S.C. § 103). The Board adopted the Patent Owner’s broader claim constructions for key terms like 'magneto coupling,' leading to the institution of the IPR.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.